Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001209191-22-014652 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-02 | 2022-02-28 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $10.77 | -17.6K | 211.6K | -8% | -$189.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-28 | S | D | 4,364 | $10.77 | 195,380 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-02-28 | S | D | 3,804 | $10.77 | 199,744 | D | — | — | |
| 3 | Common | Class A Common Stock | 2022-02-28 | S | D | 5,161 | $10.77 | 203,548 | D | — | — | |
| 4 | Common | Class A Common Stock | 2022-02-28 | S | D | 2,911 | $10.77 | 208,709 | D | — | — | |
| 5 | Common | Class A Common Stock | 2022-02-28 | S | D | 1,367 | $10.77 | 211,620 | D | — | — |